arrow
B

Bernhard Doleschal

Department of Internal Medicine I for Hematology with Stem Cell Transplantation
H指数:11
被引数:636

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic management of resectable mismatch-repair deficient/microsatellite instability-high gastroesophageal adenocarcinoma: a real-world analysis from Austria

可切除错配修复缺陷/微卫星高度不稳定胃癌的疗法管理:来自奥地利的真实世界分析

2026-07-230
OA
Clinical practice and implications of biomarker testing in biliary tract cancer: an observational study☆

胆道癌中生物标志物检测的临床实践与意义:一项观察性研究☆

2025-11-040
OAAI
Real-world effectiveness and predictive biomarker analysis of TAS-102+bevacizumab vs. regorafenib vs. TAS-102 in metastatic colorectal cancer: A multicenter cohort study

TAS-102+bevacizumab对比regorafenib对比TAS-102在转移性结直肠癌中的真实世界有效性与预测性生物标志物分析:一项多中心队列研究

2024-09-010
PRE
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity
2024-08-012
OAAI
Homologous recombination repair (HRR) deficiency in biliary tract cancers: Clinical implications in subsequent therapy lines and correlation with platinum sensitivity
2024-06-010
PRE